MARINE
Mediterranean heatwaves putting farmed finfish under strain
The welfare of farmed seabream and sea bass in the Mediterranean is threatened by marine heatwaves, which are becoming increasingly frequent in the region.
Sea bass farm in Italy hit by a rare outbreak of lactococcosis
Scientists have reported a case of lactococcosis, caused by the bacterium Lactococcus garvieae, at a sea bass farm in Italy — a rare development which has prompted questions over its origins and possible wider threat.
Advanced genomics data could spark breeding revolution in European aquaculture
New genomics data on six commercially important fish species in Europe could have major implications for breeding programs, but there is work still to be done to realize the benefits.
Managing health risks in Mediterranean aquaculture’s least-controllable environment
The consolidation of Mediterranean aquaculture is standardizing production practices in the region and leading to better biosecurity management, but growing out fish in the unforgiving environment at sea poses the sort of challenge that demands realistic, practical solutions.
New approach could improve understanding of farmed seabream welfare
Analyzing proteins from the skin mucus of gilthead seabream (Sparus aurata) could offer a promising, welfare-friendly route to monitor stress levels of the fish during production cycles.
Helping Mediterranean fish farmers quickly identify disease issues
An interview with Emre Berke, DVM, PhD, field technical support associate for PHARMAQ.
Lack of coordination threatens biosecurity in Spanish marine-fish farming
Spain’s marine aquaculture industry needs to make changes in order to meet biosecurity threats, according to a new EU-backed report.
Diversity of sea bass pathogen strains highlights challenge in Mediterranean aquaculture
A new study analyzing three strains of the bacterium Vibrio harveyi found among farmed sea bass in the Mediterranean has underlined the diversity of the pathogen, which poses a severe threat to the region’s aquaculture.
Sea bass immunity to parasitic disease could lead to new treatments
No effective licensed therapies exist against amyloodiniosis, a disease of fish species caused by Amyloodinium ocellatum (AO) ectoparasites. However, new research has shown that European sea bass (ESB) can develop specific immunity to the disease, which could in turn lead to the development of vaccines.
Safety and welfare concerns drive shift to licensed anesthetic in Mediterranean aquaculture
Improving standards on Mediterranean fish farms is driving interest in Tricaine PHARMAQ — the only authorized fish anesthetic product.
